Chemistry, Manufacturing, and Controls (CMC) data is often one of the most underestimated elements in veterinary drug development. Yet when it comes time to prepare an FDA submission—whether an INAD or a full NADA—incomplete or misaligned CMC information is one of the leading causes of delay.
For companies seeking a proactive path to approval, a CMC gap assessment is an essential tool. This process helps identify technical and regulatory deficiencies early, align manufacturing with CVM expectations, and position the product for a smoother review.
In this article, we explore what a CMC gap assessment involves, when to conduct one, and how it contributes to veterinary development success.
What Is a CMC Gap Assessment?
A CMC gap assessment is a systematic review of your current development status—including drug substance, drug product, analytical methods, and manufacturing processes—to evaluate alignment with regulatory expectations.
It asks:
- What data do we have?
- What data is missing or incomplete?
- Does existing documentation meet CVM standards?
- Are we ready to move into the next phase; clinical trials/submission?
For animal health products, a gap assessment must also consider species-specific factors, such as palatability, dosage flexibility, and excipient tolerability.
Why Is CMC Readiness Critical in Veterinary Submissions?
Unlike human health, veterinary development often operates on leaner budgets and accelerated timelines. But the FDA’s Center for Veterinary Medicine (CVM) still expects robust, well-documented CMC data to support product safety, efficacy, and consistency.
Common CMC challenges in veterinary submissions include:
- Use of excipients not validated for animal species
- Incomplete stability data
- Missing process validation for key manufacturing steps
- Poorly justified container closure systems
- Analytical methods lacking validation or transfer plans
These gaps can trigger CVM questions, hold letters, or re-review cycles—slowing time to market.
What Does a CMC Gap Assessment Include?
At a minimum, a veterinary CMC gap assessment should review:
- Drug substance: Source, specifications, process controls, and impurity profile
- Drug product: Formulation rationale, batch records, manufacturing process
- Analytical methods: Method development, validation, and transfer readiness
- Stability data: Protocols aligned with VICH guidelines, ongoing studies
- Packaging and labeling: Container closure selection and compatibility
- Quality systems: GMP readiness, documentation practices, and change control
The goal is to create a roadmap to regulatory compliance—clearly identifying what's ready, what needs refinement, and what still requires generation.
When to Conduct a Gap Assessment
A CMC gap assessment can be valuable at multiple stages:
- Before pivotal trials: Ensures final formulation and process are well-supported
- Before INAD submission: Aligns initial data with CVM expectations
- Pre-NADA: Confirms all technical sections are complete and defensible
- Post-acquisition or tech transfer: Evaluates inherited data sets for completeness
Early assessments help you avoid costly surprises later in development.
How DSI Supports Veterinary CMC Readiness
DS Inpharmatics brings decades of experience in CMC regulatory strategy and offers tailored gap assessment services for veterinary sponsors. Our support includes:
- End-to-end review of drug substance and drug product CMC data
- Evaluation of analytical, stability, and process development readiness
- Customized gap reports with clear action steps and timelines
- Strategic alignment with CVM’s regulatory expectations
- Support in drafting or refining CMC sections for INADs and NADAs
Whether you’re preparing for a regulatory submission or need to validate legacy data, we help ensure your CMC package is complete, consistent, and approval-ready.
Final Thoughts
In the fast-moving world of veterinary medicine, a proactive CMC gap assessment is one of the smartest investments a sponsor can make. It uncovers hidden risks, clarifies next steps, and helps keep your development program on track.
Need help evaluating your CMC readiness?
Let DSI guide your gap assessment with precision and insight—so your veterinary product moves from concept to approval with confidence.
